Klebsiella pneumoniae: adaptive immune landscapes and vaccine horizons
PL Wantuch, DA Rosen - Trends in Immunology, 2023 - cell.com
Klebsiella pneumoniae is among the most common antibiotic-resistant pathogens causing
nosocomial infections. Additionally, it is a leading cause of neonatal sepsis and childhood …
nosocomial infections. Additionally, it is a leading cause of neonatal sepsis and childhood …
Prevalence of hypervirulent and carbapenem-resistant Klebsiella pneumoniae under divergent evolutionary patterns
D Tian, X Liu, W Chen, Y Zhou, D Hu… - Emerging microbes & …, 2022 - Taylor & Francis
ABSTRACT K1/K2 hvKP strains acquire carbapenem-resistance plasmids, known as CR-
hvKp, and carbapenem-resistant Klebsiella pneumoniae (CRKP) strains obtain virulence …
hvKp, and carbapenem-resistant Klebsiella pneumoniae (CRKP) strains obtain virulence …
Host defense against the infection of Klebsiella pneumoniae: New strategy to kill the bacterium in the era of antibiotics?
Z Liang, Y Wang, Y Lai, J Zhang, L Yin, X Yu… - Frontiers in Cellular …, 2022 - frontiersin.org
Klebsiella pneumonia e (K. pneumoniae) is a typical gram-negative iatrogenic bacterium
that often causes bacteremia, pneumonia and urinary tract infection particularly among …
that often causes bacteremia, pneumonia and urinary tract infection particularly among …
Design and fabrication of a vaccine candidate based on rOmpA from Klebsiella pneumoniae encapsulated in silk fibroin-sodium alginate nanoparticles against …
The present study describes the design and fabrication of a novel vaccine candidate based
on the outer membrane protein A (rOmpA) from Klebsiella pneumoniae (K. pneumoniae) …
on the outer membrane protein A (rOmpA) from Klebsiella pneumoniae (K. pneumoniae) …
The Type VI Secretion System Contributes to the Invasiveness of Liver Abscess Caused by Klebsiella pneumoniae
H Wang, Y Guo, Z Liu, Z Chang - The Journal of Infectious …, 2023 - academic.oup.com
Background Klebsiella pneumoniae liver abscess (KPLA) with extrahepatic migratory
infections is defined as invasive KPLA (IKPLA). The type VI secretion system (T6SS) is …
infections is defined as invasive KPLA (IKPLA). The type VI secretion system (T6SS) is …
[HTML][HTML] Vaccine value profile for Klebsiella pneumoniae
Z Dangor, N Benson, JA Berkley, J Bielicki, MW Bijsma… - Vaccine, 2024 - Elsevier
Klebsiella pneumoniae causes community-and healthcare-associated infections in children
and adults. Globally in 2019, an estimated 1.27 million (95% Uncertainty Interval [UI]: 0.91 …
and adults. Globally in 2019, an estimated 1.27 million (95% Uncertainty Interval [UI]: 0.91 …
Clinical and Molecular Characteristics and Antibacterial Strategies of Klebsiella pneumoniae in Pyogenic Infection
Z Yang, R Zhou, Y Chen, X Zhang, L Liu… - Microbiology …, 2023 - Am Soc Microbiol
Treatment of Klebsiella pneumoniae causing pyogenic infections is challenging. The clinical
and molecular characteristics of Klebsiella pneumoniae causing pyogenic infections are …
and molecular characteristics of Klebsiella pneumoniae causing pyogenic infections are …
Challenges in development of vaccines directed toward antimicrobial resistant bacterial species
M Brazzoli, D Piccioli, F Marchetti - Human Vaccines & …, 2023 - Taylor & Francis
Antimicrobial resistance (AMR) is considered by WHO one of the top ten public health
threats. New control strategies involving concerted actions of both public and private sectors …
threats. New control strategies involving concerted actions of both public and private sectors …
Immunostimulatory chimeric protein encapsulated in gelatin nanoparticles elicits protective immunity against Pseudomonas aeruginosa respiratory tract infection
This study presents the design and fabrication of an innovative vaccine candidate targeting
Pseudomonas aeruginosa (P. aeruginosa). The vaccine consists of gelatin nanoparticles …
Pseudomonas aeruginosa (P. aeruginosa). The vaccine consists of gelatin nanoparticles …
A New Live Auxotrophic Vaccine Induces Cross-Protection against Klebsiella pneumoniae Infections in Mice
The development of a whole-cell vaccine from bacteria auxotrophic for D-amino acids
present in the bacterial cell wall is considered a promising strategy for providing protection …
present in the bacterial cell wall is considered a promising strategy for providing protection …